vs
Cheer Holding, Inc.（CHR）与科睿唯安（CLVT）财务数据对比。点击上方公司名可切换其他公司
科睿唯安的季度营收约是Cheer Holding, Inc.的8.7倍（$617.0M vs $71.0M）。Cheer Holding, Inc.净利率更高（10.9% vs 0.5%，领先10.4%）。Cheer Holding, Inc.同比增速更快（-0.1% vs -6.9%）
祺睿控股有限公司是一家多元化控股企业，主要在中国市场运营，核心业务板块覆盖幼儿教育服务、移动生活平台、数字内容供给及面向家庭和企业合作伙伴的整合消费解决方案。
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
CHR vs CLVT — 直观对比
营收规模更大
CLVT
是对方的8.7倍
$71.0M
营收增速更快
CHR
高出6.9%
-6.9%
净利率更高
CHR
高出10.4%
0.5%
损益表 — Q2 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $71.0M | $617.0M |
| 净利润 | $7.8M | $3.1M |
| 毛利率 | 70.7% | 66.8% |
| 营业利润率 | 11.7% | 6.7% |
| 净利率 | 10.9% | 0.5% |
| 营收同比 | -0.1% | -6.9% |
| 净利润同比 | -37.5% | 101.6% |
| 每股收益（稀释后） | $0.67 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHRCLVT
| Q4 25 | — | $617.0M | ||
| Q3 25 | — | $623.1M | ||
| Q2 25 | $71.0M | $621.4M | ||
| Q1 25 | — | $593.7M | ||
| Q4 24 | — | $663.0M | ||
| Q3 24 | — | $622.2M | ||
| Q2 24 | $71.1M | $650.3M | ||
| Q1 24 | — | $621.2M |
净利润CHRCLVT
| Q4 25 | — | $3.1M | ||
| Q3 25 | — | $-28.3M | ||
| Q2 25 | $7.8M | $-72.0M | ||
| Q1 25 | — | $-103.9M | ||
| Q4 24 | — | $-191.8M | ||
| Q3 24 | — | $-65.6M | ||
| Q2 24 | $12.4M | $-304.3M | ||
| Q1 24 | — | $-75.0M |
毛利率CHRCLVT
| Q4 25 | — | 66.8% | ||
| Q3 25 | — | 65.0% | ||
| Q2 25 | 70.7% | 67.2% | ||
| Q1 25 | — | 65.1% | ||
| Q4 24 | — | 65.7% | ||
| Q3 24 | — | 66.2% | ||
| Q2 24 | 73.4% | 67.2% | ||
| Q1 24 | — | 64.9% |
营业利润率CHRCLVT
| Q4 25 | — | 6.7% | ||
| Q3 25 | — | 7.1% | ||
| Q2 25 | 11.7% | 1.1% | ||
| Q1 25 | — | -3.5% | ||
| Q4 24 | — | -9.4% | ||
| Q3 24 | — | 3.5% | ||
| Q2 24 | 16.4% | -36.9% | ||
| Q1 24 | — | 0.8% |
净利率CHRCLVT
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | -4.5% | ||
| Q2 25 | 10.9% | -11.6% | ||
| Q1 25 | — | -17.5% | ||
| Q4 24 | — | -28.9% | ||
| Q3 24 | — | -10.5% | ||
| Q2 24 | 17.5% | -46.8% | ||
| Q1 24 | — | -12.1% |
每股收益（稀释后）CHRCLVT
| Q4 25 | — | $0.00 | ||
| Q3 25 | — | $-0.04 | ||
| Q2 25 | $0.67 | $-0.11 | ||
| Q1 25 | — | $-0.15 | ||
| Q4 24 | — | $-0.27 | ||
| Q3 24 | — | $-0.09 | ||
| Q2 24 | $1.23 | $-0.46 | ||
| Q1 24 | — | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $329.2M |
| 总债务越低越好 | — | $4.3B |
| 股东权益账面价值 | $322.1M | $4.8B |
| 总资产 | $362.7M | $11.1B |
| 负债/权益比越低杠杆越低 | — | 0.89× |
8季度趋势，按日历期对齐
现金及短期投资CHRCLVT
| Q4 25 | — | $329.2M | ||
| Q3 25 | — | $318.7M | ||
| Q2 25 | — | $362.6M | ||
| Q1 25 | — | $354.0M | ||
| Q4 24 | — | $295.2M | ||
| Q3 24 | — | $388.5M | ||
| Q2 24 | $186.1M | $376.4M | ||
| Q1 24 | — | $361.8M |
总债务CHRCLVT
| Q4 25 | — | $4.3B | ||
| Q3 25 | — | $4.4B | ||
| Q2 25 | — | $4.5B | ||
| Q1 25 | — | $4.5B | ||
| Q4 24 | — | $4.5B | ||
| Q3 24 | — | $4.6B | ||
| Q2 24 | — | $4.6B | ||
| Q1 24 | — | $4.6B |
股东权益CHRCLVT
| Q4 25 | — | $4.8B | ||
| Q3 25 | — | $4.9B | ||
| Q2 25 | $322.1M | $5.0B | ||
| Q1 25 | — | $5.0B | ||
| Q4 24 | — | $5.1B | ||
| Q3 24 | — | $5.5B | ||
| Q2 24 | $286.1M | $5.6B | ||
| Q1 24 | — | $5.9B |
总资产CHRCLVT
| Q4 25 | — | $11.1B | ||
| Q3 25 | — | $11.2B | ||
| Q2 25 | $362.7M | $11.4B | ||
| Q1 25 | — | $11.5B | ||
| Q4 24 | — | $11.5B | ||
| Q3 24 | — | $12.0B | ||
| Q2 24 | $333.2M | $12.1B | ||
| Q1 24 | — | $12.5B |
负债/权益比CHRCLVT
| Q4 25 | — | 0.89× | ||
| Q3 25 | — | 0.90× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.90× | ||
| Q4 24 | — | 0.88× | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.83× | ||
| Q1 24 | — | 0.79× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.9M | $159.9M |
| 自由现金流经营现金流 - 资本支出 | — | $89.2M |
| 自由现金流率自由现金流/营收 | — | 14.5% |
| 资本支出强度资本支出/营收 | — | 11.5% |
| 现金转化率经营现金流/净利润 | 0.51× | 51.58× |
| 过去12个月自由现金流最近4个季度 | — | $365.3M |
8季度趋势，按日历期对齐
经营现金流CHRCLVT
| Q4 25 | — | $159.9M | ||
| Q3 25 | — | $181.1M | ||
| Q2 25 | $3.9M | $116.3M | ||
| Q1 25 | — | $171.2M | ||
| Q4 24 | — | $141.3M | ||
| Q3 24 | — | $202.9M | ||
| Q2 24 | $-6.7M | $126.2M | ||
| Q1 24 | — | $176.2M |
自由现金流CHRCLVT
| Q4 25 | — | $89.2M | ||
| Q3 25 | — | $115.5M | ||
| Q2 25 | — | $50.3M | ||
| Q1 25 | — | $110.3M | ||
| Q4 24 | — | $59.1M | ||
| Q3 24 | — | $126.3M | ||
| Q2 24 | — | $60.3M | ||
| Q1 24 | — | $111.8M |
自由现金流率CHRCLVT
| Q4 25 | — | 14.5% | ||
| Q3 25 | — | 18.5% | ||
| Q2 25 | — | 8.1% | ||
| Q1 25 | — | 18.6% | ||
| Q4 24 | — | 8.9% | ||
| Q3 24 | — | 20.3% | ||
| Q2 24 | — | 9.3% | ||
| Q1 24 | — | 18.0% |
资本支出强度CHRCLVT
| Q4 25 | — | 11.5% | ||
| Q3 25 | — | 10.5% | ||
| Q2 25 | — | 10.6% | ||
| Q1 25 | — | 10.3% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | — | 12.3% | ||
| Q2 24 | — | 10.1% | ||
| Q1 24 | — | 10.4% |
现金转化率CHRCLVT
| Q4 25 | — | 51.58× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.54× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CHR
暂无分部数据
CLVT
| Academia Government Group | $312.3M | 51% |
| Re Occurring Revenues | $114.1M | 18% |
| Life Sciences And Healthcare Group | $98.3M | 16% |
| Transactional Revenues | $97.1M | 16% |
